Qiulin Tang

3.1k total citations · 2 hit papers
75 papers, 2.3k citations indexed

About

Qiulin Tang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qiulin Tang has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 24 papers in Cancer Research and 20 papers in Oncology. Recurrent topics in Qiulin Tang's work include MicroRNA in disease regulation (10 papers), Hippo pathway signaling and YAP/TAZ (9 papers) and Ubiquitin and proteasome pathways (8 papers). Qiulin Tang is often cited by papers focused on MicroRNA in disease regulation (10 papers), Hippo pathway signaling and YAP/TAZ (9 papers) and Ubiquitin and proteasome pathways (8 papers). Qiulin Tang collaborates with scholars based in China, United States and Denmark. Qiulin Tang's co-authors include Hongwei Xia, Feng Bi, Huanji Xu, Feng Bi, Sheng Zhou, Gongmin Zhu, Lijiao Pei, Ming Liu, Qiyong Gong and Chenliang Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Qiulin Tang

72 papers receiving 2.3k citations

Hit Papers

Role of oncogenic KRAS in the prognosis, diagnosis and tr... 2020 2026 2022 2024 2021 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiulin Tang China 25 1.4k 1.1k 535 290 264 75 2.3k
José M.A. Moreira Denmark 31 1.8k 1.3× 670 0.6× 656 1.2× 210 0.7× 202 0.8× 79 2.8k
Dmitri Mouradov Australia 17 1.4k 1.0× 776 0.7× 535 1.0× 216 0.7× 157 0.6× 32 2.4k
Lin Lin China 28 1.4k 1.0× 1.2k 1.1× 323 0.6× 177 0.6× 155 0.6× 100 2.4k
Wei Gao China 31 1.7k 1.2× 979 0.9× 419 0.8× 202 0.7× 122 0.5× 124 2.5k
Young‐Ho Ahn South Korea 28 1.5k 1.1× 844 0.8× 508 0.9× 178 0.6× 123 0.5× 78 2.3k
Yuelin J. Zhu United States 28 1.7k 1.2× 793 0.7× 561 1.0× 341 1.2× 189 0.7× 68 2.7k
Toshiro Migita Japan 25 1.6k 1.1× 1.0k 1.0× 511 1.0× 449 1.5× 285 1.1× 38 2.4k
Anne Pradines France 30 1.7k 1.2× 1.0k 1.0× 1.1k 2.0× 609 2.1× 205 0.8× 77 2.9k
Tianzuo Zhan Germany 19 2.2k 1.6× 687 0.6× 956 1.8× 333 1.1× 195 0.7× 44 3.1k
Yoji Andrew Minamishima Japan 23 1.9k 1.3× 1.0k 1.0× 732 1.4× 175 0.6× 161 0.6× 35 2.8k

Countries citing papers authored by Qiulin Tang

Since Specialization
Citations

This map shows the geographic impact of Qiulin Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiulin Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiulin Tang more than expected).

Fields of papers citing papers by Qiulin Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiulin Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiulin Tang. The network helps show where Qiulin Tang may publish in the future.

Co-authorship network of co-authors of Qiulin Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiulin Tang. A scholar is included among the top collaborators of Qiulin Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiulin Tang. Qiulin Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chenliang, et al.. (2025). Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives. Molecular Cancer. 24(1). 265–265. 1 indexed citations
2.
Huang, Chen, et al.. (2025). Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma. Cell Biology and Toxicology. 41(1). 35–35. 2 indexed citations
3.
Ye, Di, et al.. (2024). Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(5). 189161–189161. 5 indexed citations
4.
Zhang, Chenliang, Huanji Xu, Qiulin Tang, et al.. (2024). CaMKII suppresses proteotoxicity by phosphorylating BAG3 in response to proteasomal dysfunction. EMBO Reports. 25(10). 4488–4514. 2 indexed citations
5.
Tang, Qiulin, Huanji Xu, Hongwei Xia, et al.. (2024). Endogenous Coriobacteriaceae enriched by a high-fat diet promotes colorectal tumorigenesis through the CPT1A-ERK axis. npj Biofilms and Microbiomes. 10(1). 5–5. 21 indexed citations
6.
Zhu, Gongmin, Lijiao Pei, Hongwei Xia, Qiulin Tang, & Feng Bi. (2021). Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Molecular Cancer. 20(1). 143–143. 265 indexed citations breakdown →
7.
Zhang, Huan, Huanji Xu, Chenliang Zhang, Qiulin Tang, & Feng Bi. (2021). Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis. Cell Death Discovery. 7(1). 207–207. 55 indexed citations
8.
Ma, Ji, Zhenhai Fan, Qiulin Tang, et al.. (2020). Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer. Cell Death and Disease. 11(7). 530–530. 14 indexed citations
9.
Xu, Huanji, Sheng Zhou, Qiulin Tang, Hongwei Xia, & Feng Bi. (2020). Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(1). 188394–188394. 253 indexed citations breakdown →
10.
Zhou, Sheng, Huanji Xu, Qiulin Tang, Hongwei Xia, & Feng Bi. (2019). Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway. Molecular Cancer Therapeutics. 19(1). 135–146. 35 indexed citations
11.
Hou, Wanting, Hongwei Xia, Sheng Zhou, et al.. (2019). The MEK inhibitors enhance the efficacy of sorafenib against hepatocellular carcinoma cells through reducing p-ERK rebound. Translational Cancer Research. 8(4). 1224–1232. 1 indexed citations
12.
Zhou, Sheng, Hongwei Xia, Huanji Xu, et al.. (2018). ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells. Journal of Experimental & Clinical Cancer Research. 37(1). 218–218. 26 indexed citations
13.
Xia, Hongwei, Qiulin Tang, Huanji Xu, et al.. (2017). Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation. Scientific Reports. 7(1). 40802–40802. 85 indexed citations
14.
Yuan, Dandan, Liang Chen, Mingxing Li, et al.. (2014). Isolation and characterization of circulating tumor cells from human gastric cancer patients. Journal of Cancer Research and Clinical Oncology. 141(4). 647–660. 24 indexed citations
15.
Zhu, Yajie, Jitao Zhou, Hongwei Xia, et al.. (2014). The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells. International Journal of Oncology. 44(3). 896–904. 19 indexed citations
16.
Wang, Zi, Chunmei Huang, Qian Deng, et al.. (2012). Effects of the proapoptotic regulator Bcl-2/adenovirus EIB 19-kDa-interacting protein 3 on the chemosensitivity of human colon cancer cell lines. Oncology Letters. 4(6). 1195–1202. 3 indexed citations
17.
Wang, Zi, Chunmei Huang, Qian Deng, et al.. (2011). Effects of the Proapoptotic Regulator Bcl2/Adenovirus EIB 19 kDa-Interacting Protein 3 on Radiosensitivity of Cervical Cancer. Cancer Biotherapy and Radiopharmaceuticals. 26(3). 279–286. 5 indexed citations
18.
Deng, Qian, Zhiping Li, Chunmei Huang, et al.. (2010). [Effect and mechanism of DNMT inhibitor on the reversal of multidrug resistance in human colon cancer cell line sw620/L-OHP].. PubMed. 41(6). 975–9. 2 indexed citations
19.
Liu, Ming, Lang Nan, Meng Qiu, et al.. (2010). miR‐137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. International Journal of Cancer. 128(6). 1269–1279. 144 indexed citations
20.
Tang, Qiulin, Weixing Wan, Baiqi Ning, & Hong Yuan. (2002). Properties of large-scale TIDs observed in central China. Science in China Series A Mathematics. 45(S1). 156–160. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026